Last --
Change Today 0.00 / 0.00%
Volume 0.0
All times are local (Market data is delayed by at least 15 minutes).

udg healthcare pl-unspon adr (UDRGY) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
12/4/13
P/E TM
--
Dividend
$0.39
Dividend Yield
--
Current Stock Chart for UDG HEALTHCARE PL-UNSPON ADR (UDRGY)

Related News

No related news articles were found.

udg healthcare pl-unspon adr (UDRGY) Related Businessweek News

No Related Businessweek News Found

udg healthcare pl-unspon adr (UDRGY) Details

UDG Healthcare plc, together with its subsidiaries, provides supply chain, packaging, medical, regulatory, and sales and marketing services to healthcare manufacturers and pharmacies operating in the Republic of Ireland, the United Kingdom, North America, and continental Europe. It operates through three segments: Supply Chain Services, Sharp Packaging Services, and Ashfield Commercial & Medical Services. The company offers integrated logistics and associated commercial services for pharmaceutical, biotech, and consumer companies in the areas of pharma wholesale, as well as bulk and medicine distribution. It also provides clinical and commercial packaging, storage, logistics, and project management services to the pharmaceutical and biotech industry. In addition, the company offers a range of outsourced solutions to pharmaceutical and biotech companies, including sales and marketing, healthcare communications, event management, medical affairs, and regulatory services. Further, it distributes specialist healthcare and scientific products and services, as well as provides outsourced sales, marketing, distribution, and engineering services to its clients. The company was formerly known as United Drug plc and changed its name to UDG Healthcare plc in August 2013. UDG Healthcare plc was founded in 1948 and is based in Dublin, Ireland.

8,000 Employees
Last Reported Date: 01/6/14
Founded in 1948

udg healthcare pl-unspon adr (UDRGY) Top Compensated Officers

Chief Executive Officer, Director and Member ...
Total Annual Compensation: €684.0K
Chief Financial Officer and Executive Directo...
Total Annual Compensation: €435.0K
Managing Director of Ashfield Commercial & Me...
Total Annual Compensation: €412.0K
Compensation as of Fiscal Year 2013.

udg healthcare pl-unspon adr (UDRGY) Key Developments

UDG Healthcare plc Announces Board Changes

UDG Healthcare plc confirmed that, in accordance with previous communications, Gary McGann has stepped down as Chairman and member of the Remuneration Committee with effect from 4 February 2014. The Company is also pleased to confirm the appointment of John Peter as Chairman of the Remuneration Committee.

Barry Mcgrane and Hugh Friel Retire as Members of the Board of UDG Healthcare plc

UDG Healthcare plc announced that Mr. Barry McGrane and Mr. Hugh Friel retired as a members of the board at the conclusion of the company's Annual General Meeting held on 04 February 2014.

UDG Healthcare plc Announces Group Financial Results for the First Quarter Ended December 31, 2013; Provides Financial Guidance for the Year Ending September 30, 2014

UDG Healthcare plc announced group financial results for the first quarter ended December 31, 2013. Performance for the quarter to 31 December 2013 has been satisfactory. Group revenues for the three months, measured on a constant currency basis, are ahead of the same period last year. As anticipated, reported profitability for the first quarter is below last year's levels, mainly due to the incremental financing costs associated with the September 2013 private debt placement and the one-off divisional re-branding costs, both of which are weighted towards the first half of the year. Based on the underlying trading performance for the year to date and the outlook for the remainder of the year, the group expects constant currency adjusted diluted earnings per share (EPS) for the year to September 30, 2014, before amortization of acquired intangible assets and acquisition costs, to be between 2% and 5% ahead of last year. The company expects that this result will be weighted towards the second half of the year. Excluding the increased private placement financing costs and the one-off re-branding costs noted above, underlying EPS growth for the year is expected to be 8% to 11%. The group also expects to deliver another good cash flow performance in the year, although this will be weighted towards the second half of the year due to the timing of cash inflows.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UDRGY:US $0.00 USD 0.00

UDRGY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cardinal Health Inc $68.13 USD +0.11
Celesio AG €25.06 EUR +0.13
CMIC Holdings Co Ltd ¥1,546 JPY -19.00
EPS Corp/Japan ¥972.00 JPY +31.00
Galenica AG SFr.832.50 CHF +3.50
View Industry Companies
 

Industry Analysis

UDRGY

Industry Average

Valuation UDRGY Industry Range
Price/Earnings 25.3x
Price/Sales 0.4x
Price/Book 1.7x
Price/Cash Flow 25.2x
TEV/Sales 0.1x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UDG HEALTHCARE PL-UNSPON ADR, please visit www.udghealthcare.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.